000294012 001__ 294012
000294012 005__ 20250825113844.0
000294012 0247_ $$2doi$$a10.1016/j.radonc.2024.110572
000294012 0247_ $$2pmid$$apmid:39395666
000294012 0247_ $$2ISSN$$a0167-8140
000294012 0247_ $$2ISSN$$a1879-0887
000294012 0247_ $$2altmetric$$aaltmetric:169275273
000294012 037__ $$aDKFZ-2024-02052
000294012 041__ $$aEnglish
000294012 082__ $$a610
000294012 1001_ $$aFeldman, J.$$b0
000294012 245__ $$aStudy of upright patient positioning reproducibility in image-guided proton therapy for head and neck cancers.
000294012 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2024
000294012 3367_ $$2DRIVER$$aarticle
000294012 3367_ $$2DataCite$$aOutput Types/Journal article
000294012 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1730197842_5954
000294012 3367_ $$2BibTeX$$aARTICLE
000294012 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000294012 3367_ $$00$$2EndNote$$aJournal Article
000294012 500__ $$a#EA:E041# / 2024 Oct 10:201:110572
000294012 520__ $$aTo evaluate the patient's positioning reproducibility during upright treatment with image-guided adaptive proton therapy (IGAPT) for head and neck cancers.10 head and neck (H&N) patients were treated with gantry-less IGAPT, which includes daily 3D computed tomography (CT) and two 2D kilovoltage radiographs before treatment and weekly 3DCT immediately after irradiation. All procedures were performed in the carbon chair on the 6 degrees of freedom robotic positioner.Prior to treatment we registered shifts in patient positioning using 3D/3D registration at the imaging isocenter: X = -0.1 ± 3.9 (mean ± standard deviation) mm, Y = -3.7 ± 3.5 mm, Z = 0.5 ± 6.2 mm. The corresponding vector was applied to the robotic positioner to compensate for the registered shifts, after which the patients were moved to the treatment isocenter and the following shifts were obtained there using 2D/3D registration: X = -0.31 ± 1.37 mm, Y = -0.02 ± 1.33 mm, Z = 0.59 ± 1.55 mm. Finally, the weekly follow-up 3D/3D registration showed X = -0.2 ± 1.2 mm, Y = -0.0 ± 1.4 mm, Z = 2.3 ± 2.0 mm.A novel image-guided gantry-less PT facility showed reliable results in terms of patient positioning for H&N cases during clinical trials. This fact confirmed the suitability of using gantry-less PT for H&N treatment. A small, systematic shift in the vertical direction was detected in the follow-up 3D/3D registration. The effect of this shift will be investigated in further studies with pre/post treatment 2D/3D registration. The next phase of the clinical trial of this facility is dedicated to the thorax region.
000294012 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000294012 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000294012 650_7 $$2Other$$aImage guidance
000294012 650_7 $$2Other$$aProton therapy
000294012 650_7 $$2Other$$aSeated treatment
000294012 650_7 $$2Other$$aTreatment chair
000294012 650_7 $$2Other$$aUpright CT
000294012 650_7 $$2Other$$aUpright treatment
000294012 7001_ $$0P:(DE-He78)0704701d58e3a0d5f45fbd1018d5aa77$$aPryanichnikov, Alexander$$b1$$eFirst author$$udkfz
000294012 7001_ $$aShwartz, D.$$b2
000294012 7001_ $$aHillman, Y.$$b3
000294012 7001_ $$aWygoda, M.$$b4
000294012 7001_ $$aBlumenfeld, P.$$b5
000294012 7001_ $$aMarash, M.$$b6
000294012 7001_ $$aPopovtzer, A.$$b7
000294012 773__ $$0PERI:(DE-600)1500707-8$$a10.1016/j.radonc.2024.110572$$gp. 110572 -$$p110572$$tRadiotherapy and oncology$$v201$$x0167-8140$$y2024
000294012 8564_ $$uhttps://inrepo02.dkfz.de/record/294012/files/1-s2.0-S0167814024035503-main.pdf
000294012 8564_ $$uhttps://inrepo02.dkfz.de/record/294012/files/1-s2.0-S0167814024035503-main.pdf?subformat=pdfa$$xpdfa
000294012 909CO $$ooai:inrepo02.dkfz.de:294012$$pVDB
000294012 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0704701d58e3a0d5f45fbd1018d5aa77$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000294012 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000294012 9141_ $$y2024
000294012 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000294012 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bRADIOTHER ONCOL : 2022$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-21
000294012 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bRADIOTHER ONCOL : 2022$$d2023-10-21
000294012 9201_ $$0I:(DE-He78)E041-20160331$$kE041$$lMed. Physik in der Radioonkologie$$x0
000294012 9200_ $$0I:(DE-He78)E041-20160331$$kE041$$lMed. Physik in der Radioonkologie$$x0
000294012 980__ $$ajournal
000294012 980__ $$aVDB
000294012 980__ $$aI:(DE-He78)E041-20160331
000294012 980__ $$aUNRESTRICTED